A Study to Evaluate the Safety, Tolerability, and Immunogenicity of V116 in Pneumococcal Vaccine-experienced Adults (V116-006, STRIDE-6)
Clinical trial NCT05420961 · COMPLETED
Trial details
- NCT number
- NCT05420961
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-07-12
- Primary completion
- 2023-05-16
- Enrollment
- 717
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.